Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
Eli Lilly & Co. Receives Buy Rating from David Risinger Due to Promising Tirzepatide Trial Results and Competitive Tolerability
Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...
Eli Lilly price target lowered to $1,190 from $1,250 at Citi
Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...
rsvplive2d
Kerry Katona 'cried her eyes out' during surprise reunion with daughter Lilly-Sue
Kerry has opened up about her daughter Lilly-Sue surprising her with a visit recently - her second eldest daughter moved to ...
All lanes closed on Brent Spence Bridge after police chase ends in crash
The Buffalo Bills almost did it. In the closing moments of the AFC title game, they had the two-time defending Super Bowl ...
One dead after having medical emergency in Bradford County crash
Over 1.1 million people were murdered at Auschwitz, including nearly a million Jews. On the day of liberation 80 years ago, ...
Investors betting on the Trump trade may be missing some real risks
Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.
Purdue University3d
Initiative multiplies efforts to increase number of math teachers in Indy area
Purdue Global, with support from the Lilly Foundation, is introducing a new initiative to assist paraeducators in Marion County to become licensed math teachers by working with MathTrack Institute.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.